Biogen (BIIB) Change in Taxes (2014 - 2026)

Biogen (BIIB) posted quarterly Change in Taxes of $18.4 million for Q1 2026, down 73.37% year-over-year from $69.1 million in Q1 2025, and up 109.48% on a QoQ basis from -$194.0 million in Q4 2025.

Biogen (BIIB) Change in Taxes (2014 - 2026) Analysis & Trends

Biogen (BIIB) has reported Change in Taxes for 13 consecutive years, with $18.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Taxes fell 73.37% year-over-year to $18.4 million; the TTM figure through Mar 2026 stood at -$1.0 billion (down 773.43% YoY), while the FY2025 annual figure was -$958.1 million, down 1320.51% from the prior year.
  • Change in Taxes came in at $18.4 million for Q1 2026 at Biogen, up from -$194.0 million in the prior quarter.
  • The five-year high for Change in Taxes was $101.9 million in Q1 2022, with the low at -$603.8 million in Q2 2025.
  • Average Change in Taxes over 5 years is -$76.6 million, with a median of -$32.4 million recorded in 2023.
  • The largest YoY upside for Change in Taxes was 3240.91% in 2025 against a maximum downside of 10878.18% in 2025.
  • Year by year, Change in Taxes stood at -$42.1 million in 2022, then plunged by 337.53% to -$184.2 million in 2023, then surged by 108.9% to $16.4 million in 2024, then slumped by 1282.93% to -$194.0 million in 2025, then jumped by 109.48% to $18.4 million in 2026.
  • According to Business Quant data, Change in Taxes over the past three periods registered $18.4 million, -$194.0 million, and -$229.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -81.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -526.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 71.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -29.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 18.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.40 Mn
Mar 31, 2026 18.40 Mn
Dec 31, 2025 -194.00 Mn
Dec 31, 2025 -194.00 Mn
Sep 30, 2025 -229.40 Mn
Sep 30, 2025 -229.40 Mn
Jun 30, 2025 -603.80 Mn
Jun 30, 2025 -603.80 Mn
Mar 31, 2025 69.10 Mn
Mar 31, 2025 69.10 Mn
Dec 31, 2024 16.40 Mn
Dec 31, 2024 16.40 Mn
Sep 30, 2024 69.80 Mn
Sep 30, 2024 69.80 Mn
Jun 30, 2024 -5.50 Mn
Jun 30, 2024 -5.50 Mn
Mar 31, 2024 -2.20 Mn
Mar 31, 2024 -2.20 Mn
Dec 31, 2023 -184.20 Mn
Dec 31, 2023 -184.20 Mn